Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$305M |
| 2 |
Tesla
TSLA
|
+$304M |
| 3 |
ExxonMobil
XOM
|
+$277M |
| 4 |
Warner Bros
WBD
|
+$263M |
| 5 |
Linde
LIN
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$403M |
| 2 |
CERN
Cerner Corp
CERN
|
+$371M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$310M |
| 4 |
Philip Morris
PM
|
+$254M |
| 5 |
S&P Global
SPGI
|
+$233M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.19% |
| 2 | Healthcare | 14.61% |
| 3 | Financials | 12.06% |
| 4 | Consumer Discretionary | 9.25% |
| 5 | Industrials | 8.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRC
2626
DELISTED
MRC Global
MRC
| $2.91M | ﹤0.01% |
292,122
-45,424
| -13% | -$504K |
|
2627
Genco Shipping & Trading
GNK
$1.15B
| $2.91M | ﹤0.01% |
150,348
-22,662
| -13% | -$511K |
|
|
MOFG
2628
DELISTED
MidWestOne Financial Group
MOFG
| $2.88M | ﹤0.01% |
97,089
-6,565
| -6% | -$199K |
|
2629
Schwab US Large- Cap ETF
SCHX
$74.9B
| $2.88M | ﹤0.01% |
193,551
+1,920
| +1% | +$31.1K |
|
2630
Procept Biorobotics
PRCT
$1.24B
| $2.88M | ﹤0.01% |
87,967
+65,888
| +298% | +$2.4M |
|
2631
Nuveen ESG Mid-Cap Value ETF
NUMV
$460M
| $2.87M | ﹤0.01% |
93,687
+20,286
| +28% | +$683K |
|
2632
Rackspace Technology
RXT
$1.07B
| $2.87M | ﹤0.01% |
399,890
-16,846
| -4% | -$152K |
|
2633
Zai Lab
ZLAB
$2.91B
| $2.87M | ﹤0.01% |
82,590
+9,490
| +13% | +$335K |
|
2634
VSE Corp
VSEC
$6.79B
| $2.86M | ﹤0.01% |
76,057
-7,763
| -9% | -$305K |
|
2635
Atlanta Braves Holdings Series B
BATRK
$3.44B
| $2.86M | ﹤0.01% |
119,018
-4,541
| -4% | -$115K |
|
2636
Green Brick Partners
GRBK
$3.03B
| $2.85M | ﹤0.01% |
145,880
-17,124
| -11% | -$359K |
|
2637
Grid Dynamics Holdings
GDYN
$629M
| $2.85M | ﹤0.01% |
169,550
-3,180
| -2% | -$52K |
|
2638
HBT Financial
HBT
$1.35B
| $2.85M | ﹤0.01% |
159,515
-882
| -0.5% | -$15.5K |
|
|
KYNB
2639
Kyntra Bio
KYNB
$28.5M
| $2.83M | ﹤0.01% |
10,733
-501
| -4% | -$128K |
|
2640
Allogene Therapeutics
ALLO
$708M
| $2.83M | ﹤0.01% |
248,381
-50,866
| -17% | -$452K |
|
2641
Aclaris Therapeutics
ACRS
$851M
| $2.82M | ﹤0.01% |
202,199
+16,603
| +9% | +$233K |
|
|
SPYM
2642
State Street SPDR Portfolio S&P 500 ETF
SPYM
$169B
| $2.81M | ﹤0.01% |
63,376
-14,325
| -18% | -$690K |
|
|
RETA
2643
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $2.81M | ﹤0.01% |
92,308
-28,367
| -24% | -$846K |
|
2644
Oil-Dri
ODC
$1.31B
| $2.81M | ﹤0.01% |
183,078
+2,794
| +2% | +$36.6K |
|
2645
Mirion Technologies
MIR
$3.96B
| $2.8M | ﹤0.01% |
486,739
+437,783
| +894% | +$3.22M |
|
2646
Clover Health Investments
CLOV
$2.44B
| $2.8M | ﹤0.01% |
1,309,998
+1,183,723
| +937% | +$3.15M |
|
2647
FlexShares Global Upstream Natural Resources Index Fund
GUNR
$7.04B
| $2.78M | ﹤0.01% |
70,169
+10,139
| +17% | +$458K |
|
2648
The RMR Group
RMR
$346M
| $2.78M | ﹤0.01% |
98,126
-8,537
| -8% | -$246K |
|
|
VIA
2649
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $2.78M | ﹤0.01% |
72,634
+772
| +1% | +$30.3K |
|
2650
First Bancorp
FNLC
$402M
| $2.78M | ﹤0.01% |
92,279
-3,878
| -4% | -$113K |
|
Similar funds
Bank of New York Mellon's Q2 2022 Portfolio in Review
As of Q2 2022, Bank of New York Mellon held 4,820 positions worth $438B, down 15% from $516B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Bank of New York Mellon's Q2 2022 filing shows 167 new, 1,786 increased, 2,376 reduced and 241 closed positions. Its largest new stake was Hess Midstream: 1,736,004 shares worth $48.6M. The largest sale was Apple, an estimated $403M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q2 2022 buy was Hess Midstream: 1,736,004 shares worth $48.6M.
- Bank of New York Mellon added most to Goldman Sachs in Q2 2022, an estimated $305M increase.
- Bank of New York Mellon's biggest Q2 2022 reduction was Apple, cutting an estimated $403M.
- Bank of New York Mellon fully exited Cerner Corp in Q2 2022, selling an estimated $371M.
- Bank of New York Mellon's ten largest holdings make up 19% of its $438B portfolio in Q2 2022.
- Bank of New York Mellon opened 167 new positions and closed 241 in Q2 2022.
- Bank of New York Mellon's portfolio value fell 15% quarter-over-quarter to $438B.
Based on Bank of New York Mellon's 13F filing for Q2 2022, filed 15 Aug 2022.